Rybak S M, Auld D S, St Clair D K, Yao Q Z, Fett J W
Center for Biochemical and Biophysical Sciences and Medicine, Harvard Medical School, Boston, Massachusetts 02115.
Biochem Biophys Res Commun. 1989 Jul 14;162(1):535-43. doi: 10.1016/0006-291x(89)92030-5.
Synthetic peptides corresponding to the C-terminal region of angiogenin (Ang) inhibit the enzymatic and biological activities of the molecule while peptides from the N-terminal region do not affect either activity. The peptide Ang(108-121) transiently abolishes the inhibition of cell-free protein synthesis caused by angiogenin coincidentally with its cleavage of reticulocyte RNA. Several C-terminal peptides also inhibit nuclease activity of angiogenin when tRNA is the substrate. Furthermore, peptide Ang(108-123) significantly decreases neovascularization elicited by angiogenin in the chick chorioallantoic membrane assay.
与血管生成素(Ang)C末端区域对应的合成肽可抑制该分子的酶活性和生物学活性,而来自N末端区域的肽则不影响任何一种活性。肽Ang(108 - 121) 可短暂消除血管生成素对无细胞蛋白质合成的抑制作用,同时伴随着其对网织红细胞RNA的切割。当以tRNA为底物时,几种C末端肽也可抑制血管生成素的核酸酶活性。此外,在鸡胚绒毛尿囊膜试验中,肽Ang(108 - 123) 可显著减少血管生成素诱导的新血管形成。